Effects of Power Mobility on Young Children With Severe Motor Impairments

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT01028833
First received: December 7, 2009
Last updated: February 6, 2012
Last verified: February 2012

December 7, 2009
February 6, 2012
January 2009
December 2012   (final data collection date for primary outcome measure)
  • Merrill-Palmer-Revised [ Time Frame: Entry, 6-months, and 12-months ] [ Designated as safety issue: No ]
  • Pediatric Evaluation of Disability Inventory [ Time Frame: Entry, 6-months, 12-months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01028833 on ClinicalTrials.gov Archive Site
  • Child Health Status [ Time Frame: Entry ] [ Designated as safety issue: No ]
  • Two-position object permanence test [ Time Frame: Entry, 6 months, 12 months ] [ Designated as safety issue: No ]
  • Nonspeech Test [ Time Frame: Entry, 6 month, 12 months ] [ Designated as safety issue: No ]
  • Home Observation Measure of the Environment [ Time Frame: Entry, 6 months, 12 months ] [ Designated as safety issue: No ]
  • Parenting Stress Inventory [ Time Frame: Entry, 6 months, 12 months ] [ Designated as safety issue: No ]
  • Center for Epidemiologic Studies Depression Scale (CES-D) [ Time Frame: Entry, 6 months, 12 months ] [ Designated as safety issue: No ]
  • Hollingshead Scale [ Time Frame: Entry ] [ Designated as safety issue: No ]
Same as current
 
 
 
Effects of Power Mobility on Young Children With Severe Motor Impairments
Learning Early Travel Skills: Effects of Power Mobility on the Development and Function of Young Children With Severe Motor Impairments

The purpose this study is to determine the effects of power mobility on the development and function of young children of young children whose severe physical disabilities limit their exploratory behaviors and may unnecessarily restrict their cognitive, communication, and social-emotional development.

 
Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
  • Cerebral Palsy
  • Arthrogryposis
  • Spinal Muscular Atrophy
  • Other Central Nervous System or Musculoskeletal Disorders
  • Other: Power mobility
    Project staff will use structured power mobility training program to teach the children to use the power mobility devices. Project staff will schedule 1-hour sessions with each family 3 times per week for the first month of the project and will decrease in the following manner as the child becomes proficient and develops basic wheelchair maneuvering skills: two one-hour session per week for 4 weeks; one one-hour session per week for 4 weeks; two one-hour sessions per month for 4 weeks; one one-hour session per month for the remainder of the study.
  • Other: No intervention
    Children in the control group will not receive any additional intervention, but will continue to receive the early intervention or other services they were receiving prior to enrollment in this study.
  • Experimental: Power mobility
    Intervention: Other: Power mobility
  • No Intervention: Control
    Intervention: Other: No intervention
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
40
December 2012
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Must be between 14- and 30-months of age
  • Must have clinical diagnosis of a motor impairment that prevents functional independent mobility
  • Must have adequate vision and hearing to use power mobility device safely
  • Must have cognitive abilities equivalent to a 12-month level or alertness and interest in the environment that suggests a trial of power mobility is warranted
Both
14 Months to 30 Months
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01028833
H327A080006
No
University of Oklahoma
University of Oklahoma
 
Principal Investigator: Maria A. Jones, PT, PhD University of Oklahoma
University of Oklahoma
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP